0001471242-12-000680.txt : 20120516 0001471242-12-000680.hdr.sgml : 20120516 20120516123451 ACCESSION NUMBER: 0001471242-12-000680 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120516 FILED AS OF DATE: 20120516 DATE AS OF CHANGE: 20120516 EFFECTIVENESS DATE: 20120516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDISWIPE INC. CENTRAL INDEX KEY: 0001040850 STANDARD INDUSTRIAL CLASSIFICATION: TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813] IRS NUMBER: 208484256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15673 FILM NUMBER: 12847969 BUSINESS ADDRESS: STREET 1: 4400 PGA BLVD. SUITE 900 CITY: PALM BEACH GARDENS STATE: FL ZIP: 33410 BUSINESS PHONE: 3053969097 MAIL ADDRESS: STREET 1: 4400 PGA BLVD. SUITE 900 CITY: PALM BEACH GARDENS STATE: FL ZIP: 33410 FORMER COMPANY: FORMER CONFORMED NAME: CANNABIS MEDICAL SOLUTIONS, INC. DATE OF NAME CHANGE: 20100305 FORMER COMPANY: FORMER CONFORMED NAME: COMMERCE ONLINE, INC. DATE OF NAME CHANGE: 20090720 FORMER COMPANY: FORMER CONFORMED NAME: Seraph Security, Inc. DATE OF NAME CHANGE: 20090408 NT 10-Q 1 mwipnt10q0516.htm

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

SEC File Number: 000-1321002

 

 

 

Form 10-K ☐   Form 20-F ☐   Form 10-K ☐     Form 10-Q ☑    Form 10-D ☐    Form N-SAR ☐

Form N-CSR ☐

 

For period ended: March 31, 2012

 

Transition Report on Form 10-K

Transition Report on Form 20-F

Transition Report on Form 11-K

Transition Report on Form 10-Q

Transition Report on Form N-SAR

For the Transition Period Ended: N/A

 

 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

PART I B REGISTRANT INFORMATION

 

Mediswipe, Inc.

Full Name of Registrant:

 

 
477 S Rosemary Ave, Suite 202
Address of Principal Executive Office
 
West Palm Beach, FL. 33401
City, State and Zip Code

 

PART II B RULES 12b-25 (b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.

 

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached, if applicable.

 
 

PART III B NARRATIVE

 

The Company is unable to file its quarterly report on Form 10-Q for the period ended March 31, 2012 within the prescribed time period due to its difficulty in completing and obtaining required financial and other information without unreasonable effort and expense.

 

PART IV B OTHER INFORMATION

 

(1)Name and telephone number of person to contact in regard to this notification

 

Barry Hollander   561   514-9042
(Name)   (Area Code)   (Telephone Number)

 

(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

☑ Yes ☐ No

 

(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

☐ Yes ☑ No

 

 

Mediswipe, Inc.
(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Date: May 16, 2012

By: /s/ Barry Hollander

Name: Barry Hollander

Title: Chief Financial Officer